JEN.DEJEN.DEXETRA
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank69
5Y CAGR-2.0%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-2.0%/yr
Long-term compound
Percentile
P69
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q3 202537.95%
Q2 202534.47%
Q1 2025-56.69%
Q4 2024-4.47%
Q3 20248.37%
Q2 202444.90%
Q1 2024-50.92%
Q4 202349.92%
Q3 2023-7.10%
Q2 202390.79%
Q1 2023-60.65%
Q4 202260.81%
Q3 2022-2.00%
Q2 2022579.55%
Q1 2022-83.05%
Q4 2021-10.19%
Q3 2021-23.44%
Q2 2021501.51%
Q1 2021-82.37%
Q4 2020124.08%
Q3 202042.07%
Q2 2020565.06%
Q1 2020-94.42%
Q4 201925.28%
Q3 201933.50%
Q2 201951.43%
Q1 2019-55.82%
Q4 201820.99%
Q3 20189.13%
Q2 20185.28%
Q1 20185.96%
Q4 2017-14.05%
Q3 201726.01%
Q2 201765.60%
Q1 2017-47.68%
Q4 201618.50%
Q3 20161.21%
Q2 201680.07%
Q1 2016-25.92%
Q4 2015-25.66%